Hospital.Help

Lund – Swedish researchers have taken an important step towards introducing a blood test for the (early) diagnosis of Alzheimer’s disease. The test, which determines the proportion of phosphorylated Tau217 in the total Tau 217, supplemented by the Abeta42/40 ratio, detected the disease more frequently in a comparative study than general practitioners or neurologists in a specialist outpatient clinic. The results were presented at a conference of the Alzheimer’s Association in…